Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Maybe but I still will make money.
I think this applies to the oil and gas business that never happened. They are basically acquiring the Avant diagnostics to bring that entity public to market the OvaDx test and bring it public. Good times
I think the original public company was named Orion or Oreon something
Gotta love the market ??
This is how Avant is going public through being acquired.
It's inevitable
Just load up and wait and don't be disturbed by daily fluctuations. We're going to see a huge run in the near future.
It will come at the right time.
General the opportunity is here for u as well. P&d or not. It's all about potentiality and timing
Very true
Welcome and good luck.
No more S-1
They are being bought and going public that way.
Oreo will probably change name and market and become avant diagnostics.
It's possible. We shall see
I as well.
Mark Schena did the ALS ice bucket challenge. That was cool to do.
Good article.
Good news, so they are looking to be worth billions.
I agree. This is a great buying opportunity for us. Since Gen FocalinXR was approved, it validated the proprietary controlled release technology that Intelli created, thus the approvals for the pipeline are highly likely.
If your looks at the past week, there has been a lot of buying, so a few are buying up. Insiders.
Believe me I know the tricks used, but where is IPCI executives play in this. They have turned a blind eye.
I don't count interviews on seeking alpha as legitimate PR.
So, my conclusion is that there is some behind the scenes deals to acquire cheap shares to make a 100% or greater gain for a few insiders.
This is actually pretty ridiculous that the share price of IPCI has declined so much, with no intervention from the company.
It would appear that way. The market has responded negatively to the lack of transparency.
Earnings is out
Assume all message board people are FOS and you will be okay.
Good news, that's why ArrayIt is going IDE for OvaDx. We should here something soon about that.
Good volume and movement north today.
The leaders at intellipharmaceutics know they have a blockbuster with Rexista, so they are confident that they can demand top dollar in a partnership or go at it alone.
Investors should know this. Any significant positive news relating to Rexista near term and we move up fast in share price.
I doubt $2.50 range holds until 2016. the expansion has already started with the first approval, so it is just a matter of time.
Factor in the pending ANDAs
I think there will be increasing buyout offers in the future.
The company is setting up to be a billion dollar market cap company.
Also, it appears from this interview with the CFO that IPCI IS SEVERELY UNDERVALUED. Due partly to managements' position to curtail news releases for the time being.
The ANDA drug delivery technology has been validated, by the FDA approval of the generic of FocalinXR, and the good percentage of market share for the two strengths currently sold.
So, the conclusion is that FDA APPROVAL for three new ANDA generics will probably occur this year, or early next year which puts IPCI to $10+.
This oversold opportunity is another ground floor opportunity like late last year.
Video on how use the Arrayit blood card:
Tamarin is looking for employment.
Just google her for the past week. It should be the top hit of search results.
Thanks for the info. The short article basically says they have no clue what is going on and since they don't they can't support a buy recommendation and price target. So they really know nothing.
Typically this is not in the company's best interest, but, I think the PPS is low for an accumulation.
That's why it's important to do your own research.
It's because the whole market has been manipulated by the large firms to focus mainly on short term gains and results, and of course that is what retail traders think of nowadays. I everyone wants to get rich quick.
Someone is trying to keep the price from moving above $0.15
The company is still in development and growth. There will be ups and downs. It's important to plan your entry and exit.
This stock is clearly a long term hold, if that if your investing style.
I remember that.